Home › NDC Lookup › Labelers › Catalent Indiana, Llc

Catalent Indiana, Llc NDCs and Package Codes

This page lists NDC package records associated with labeler code 61434 (Catalent Indiana, Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

30
Package NDCs
28
Products
28
Active listings
0
Discontinued
18
Ingredients
0
Therapeutic classes
4
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
aflibercept 5
durvalumab injection, solution 2
eteplirsen 2
ansuvimab-zykl 2
Epinephrine 2
semaglutide 2
Odronextamab 2
adalimumab 1
Cemiplimab 1
rHuPH20 1
By dosage form
INJECTION, SOLUTION 18
INJECTION 7
INJECTION, POWDER, LYOPHILIZED, FO... 2
SOLUTION 1

Browse records — 28 products

Drug / product Billing NDC NADAC / unit Status
adalimumab 40 mg/.8mL INJECTION, SOLUTION Catalent · NDC 61434-0020-00 · 1440 SYRINGE in 1 CASE (61434-020-00) / .8 mL in 1 SYRINGE 61434-0020-00 — On market View →
aflibercept 8 mg/.07mL INJECTION, SOLUTION Catalent · NDC 61434-0062-00 · 884 VIAL in 1 CASE (61434-062-00) / .07 mL in 1 VIAL 61434-0062-00 — On market View →
aflibercept 40 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0073-00 · 352 VIAL in 1 CASE (61434-073-00) / .278 mL in 1 VIAL 61434-0073-00 — On market View →
Aflibercept 114.3 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0077-00 · 884 VIAL in 1 CASE (61434-077-00) / .263 mL in 1 VIAL 61434-0077-00 — On market View →
aflibercept 2 mg/.05mL INJECTION, SOLUTION Catalent · NDC 61434-0007-00 · 800 SYRINGE, GLASS in 1 CASE (61434-007-00) / .05 mL in 1 SYRINGE, GLASS 61434-0007-00 — On market View →
aflibercept 40 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0074-00 · 800 SYRINGE in 1 CASE (61434-074-00) / .165 mL in 1 SYRINGE 61434-0074-00 — On market View →
ansuvimab-zykl 50 mg/mL INJECTION Catalent · NDC 61434-0070-00 · 5000 mL in 1 BOTTLE (61434-070-00) 61434-0070-00 — On market View →
ansuvimab-zykl 400 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Catalent · NDC 61434-0071-00 · 224 VIAL, GLASS in 1 CASE (61434-071-00) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 61434-0071-00 — On market View →
atoltivimab, maftivimab, and odesivimab 483.3 mg/14.5mL; 483.3 mg/14.5mL; 483.3 mg/14.5mL INJECTION, SOLUTION Catalent · NDC 61434-0052-00 · 189 VIAL in 1 CASE (61434-052-00) / 14.5 mL in 1 VIAL 61434-0052-00 — On market View →
Benralizumab 10 mg/.5mL INJECTION, SOLUTION Catalent · NDC 61434-0066-00 · 1280 SYRINGE in 1 CASE (61434-066-00) / .5 mL in 1 SYRINGE 61434-0066-00 — On market View →
Cemiplimab 350 mg/7mL INJECTION Catalent · NDC 61434-0021-02 · 384 VIAL in 1 CASE (61434-021-02) / 7 mL in 1 VIAL 61434-0021-02 — On market View →
Diluent 25 mg/5mL SOLUTION Catalent · NDC 61434-0011-00 · 5 mL in 1 VIAL (61434-011-00) 61434-0011-00 — On market View →
Durvalumab 120 mg/2.4mL INJECTION, SOLUTION Catalent · NDC 61434-0038-02 · 288 VIAL in 1 CASE (61434-038-02) / 2.4 mL in 1 VIAL 61434-0038-02 — On market View →
durvalumab injection, solution 500 mg/10mL INJECTION, SOLUTION Catalent · NDC 61434-0002-10 · 288 VIAL in 1 CASE (61434-002-10) / 10 mL in 1 VIAL 61434-0002-10 — On market View →
durvalumab injection, solution 500 mg/10mL INJECTION, SOLUTION Catalent · NDC 61434-0002-10 · 288 VIAL in 1 CASE (61434-002-10) / 10 mL in 1 VIAL 61434-0002-10 — On market View →
Epinephrine 1 mg/mL INJECTION Catalent · NDC 61434-0040-01 · 1280 SYRINGE in 1 CASE (61434-040-01) / 1 mL in 1 SYRINGE 61434-0040-01 — On market View →
Epinephrine .5 mg/mL INJECTION Catalent · NDC 61434-0041-01 · 1280 SYRINGE in 1 CASE (61434-041-01) / 1 mL in 1 SYRINGE 61434-0041-01 — On market View →
eteplirsen 100 mg/2mL INJECTION Catalent · NDC 61434-0003-01 · 352 VIAL in 1 CASE (61434-003-01) / 2 mL in 1 VIAL 61434-0003-01 — On market View →
eteplirsen 500 mg/10mL INJECTION Catalent · NDC 61434-0035-01 · 288 VIAL in 1 CASE (61434-035-01) / 10 mL in 1 VIAL 61434-0035-01 — On market View →
Imetelstat sodium 188 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Catalent · NDC 61434-0069-00 · 288 VIAL in 1 CASE (61434-069-00) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 61434-0069-00 — On market View →
nivolumab 120 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0075-00 · 180 VIAL in 1 CASE (61434-075-00) / 5 mL in 1 VIAL 61434-0075-00 — On market View →
Odronextamab 2 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0064-00 · 884 VIAL in 1 CASE (61434-064-00) / 2 mL in 1 VIAL 61434-0064-00 — On market View →
Odronextamab 20 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0072-00 · 384 VIAL in 1 CASE (61434-072-00) / 4 mL in 1 VIAL 61434-0072-00 — On market View →
pozelimab 200 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0063-00 · 384 VIAL in 1 CASE (61434-063-00) / 2 mL in 1 VIAL 61434-0063-00 — On market View →
ravulizumab 100 mg/mL INJECTION, SOLUTION Catalent · NDC 61434-0076-00 · 480 VIAL in 1 CASE (61434-076-00) / 3 mL in 1 VIAL 61434-0076-00 — On market View →
rHuPH20 10 mg/10mg INJECTION Catalent · NDC 61434-0024-01 · 100000 mg in 1 BOTTLE (61434-024-01) 61434-0024-01 — On market View →
semaglutide 1.7 mg/.75mL INJECTION, SOLUTION Catalent · NDC 61434-0067-00 · 1440 SYRINGE, PLASTIC in 1 CASE (61434-067-00) / .75 mL in 1 SYRINGE, PLASTIC 61434-0067-00 — On market View →
semaglutide 2.4 mg/.75mL INJECTION, SOLUTION Catalent · NDC 61434-0068-00 · 1440 SYRINGE, PLASTIC in 1 CASE (61434-068-00) / .75 mL in 1 SYRINGE, PLASTIC 61434-0068-00 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.